Mihael Polymeropoulos

Mihael Polymeropoulos

Chief Executive Officer at VANDA PHARMACEUTICALS INC.

Net worth: 10 M $ as of 31/05/2026

66 year
Health Technology
Consumer Services
Government

Profile

Dr. Mihael H.
Polymeropoulos, MD, is a Chairman, President & Chief Executive Officer at Vanda Pharmaceuticals, Inc. Dr. Polymeropoulos was previously employed as a VP & Head-Pharmacogenetics Department by Novartis AG, a Chief-Gene Mapping Section by National Human Genome Research Institute, and a Co-Founder by Integrated Molecular Analysis of Genome Expression.
He received his undergraduate degree from the University of Patras.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/04/2026 1,588,246 ( 2.64% ) 10 M $ 31/05/2026

Mihael Polymeropoulos active positions

CompaniesPositionStart
VANDA PHARMACEUTICALS INC. Chief Executive Officer 01/05/2003

Former positions of Mihael Polymeropoulos

CompaniesPositionEnd
NOVARTIS AG Corporate Officer/Principal 01/01/2003
Corporate Officer/Principal 01/01/1998
Integrated Molecular Analysis of Genome Expression
Founder -
See the detail of Mihael Polymeropoulos's experience

Training of Mihael Polymeropoulos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Integrated Molecular Analysis of Genome Expression

Government

  1. Stock Market
  2. Insiders
  3. Mihael Polymeropoulos